Fig. 3From: SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatmentSTAT3 gene expression in PBMCs from healthy volunteers and HCV patients (SVR and NR group) prior to the initiation of PEG-IFNα and ribavirin treatment. p value ≤0.05 was considered as statistically significantBack to article page